Clinical Trials Sponsored by Intitut National du Cancer

Total 21715 results

Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Fotemustine in Treating Patients With Metastatic Melanoma

Melanoma (Skin)

France
Institut du Cancer de Montpellier - Val d'Aurelle

Suspended

Gemcitabine With Or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Bladder Cancer

Bladder Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Arginine/Omega-3 Fatty Acids/Nucleotides Nutritional Supplement in Treating Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy

Head and Neck Cancer
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Radiation Therapy During Surgery in Treating Older Women With Stage I Breast Cancer

Breast Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Unknown

Capecitabine, Irinotecan, and Oxaliplatin in Treating Patients With Metastatic Cancer

Unspecified Adult Solid Tumor, Protocol Specific

France
University of Paris 13
Intitut National du Cancer

Completed

Online Experimental Supermarket (SUPERNET)

Food Selection

France
Médecins du Monde
National Cancer Institute, France

Unknown

Improving Access to Cervical Cancer Screening

Uterine Cervical Neoplasms

France
Institut du Cancer de Montpellier - Val d'Aurelle

Unknown

Biological Factors in Predicting Response to Treatment in Patients With Esophageal Cancer or Rectal Cancer

Colorectal Cancer | Esophageal Cancer

France
McGill University
Institut National du Sport du Quebec; Apexk

Terminated

Correlation Between Changes in Measures of the Visual System and Changes in Concussion-associated Symptoms

Concussion; Syndrome

Canada
UNICANCER
Institut Bergonié; National Cancer Institute, France; Institut du Cancer de Montpellier...

Completed

Treatment of Metastatic Castrate Resistant Prostate Cancer Patients According to Circulating Tumor Cells Kinetic (TACTIK)

Chemotherapy | Castration-resistant Prostate Cancer | Prostate Carcinoma | Circulating Tumor Cells

France
Groupe Regional d'Etudes du Cancer Colorectal

Unknown

Combination Chemotherapy in Treating Patients With Colon Cancer

Colorectal Cancer

Belgium
Institut du Cancer de Montpellier - Val d'Aurelle

Not yet recruiting

Personalization of Breast Radiotherapy According to Loco-regional Recurrence Risk and Toxicity Probability (PROBA)

Breast Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Impact of an Educational Physiotherapy-Yoga Intervention on Perceived Stress in Women Treated With Brachytherapy for Cervical Cancer (KYOCOL)

Cervical Cancer | Brachytherapy

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Feasibility of 2 Interventions to Reduce Fatigue in Patients With Chemotherapy for Metastatic Colorectal Cancer (COLOFIGHT)

Colorectal Cancer Metastatic

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Evaluation of the Efficacy of a Physical Therapy-yoga-patient Educational Program for Breast Cancer Patients With Pain Due to Hormonal Therapy Treatment. (SKYPE2)

Breast Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Establishment of a Prospective Clinical-biological Database (BCBSarcome)

Sarcoma

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Clinical Database of Safe Personalized Adjuvant Breast Radiotherapy Based on Individual Radiosensitivity (SAHARA-01)

Breast Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Development of Clinical and Biological Database in Colorectal Cancer (CIRCUS)

Metastatic Colon Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Analysis of Circulating Tumor Markers in Blood (ALCINA 2)

Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Impact of Cardiac Coherence on Anxiety in Patients Operated on for a Peritoneal Carcinosis (COCOON)

Pseudomyxoma Peritonei | Peritoneal Carcinomatosis | Mesothelioma Peritoneum

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Assessing a Regorafenib-irinotecan Combination Versus Regorafenib Alone in Metastatic Colorectal Cancer Patients (NEXT-REGIRI)

Metastatic Colorectal Cancer (mCRC)

France
Institut du Cancer de Montpellier - Val d'Aurelle

Active, not recruiting

Detection of the Emergence of RAS (Rat Sarcoma Viral Oncogene Homolog) Mutations in Circulating DNA (Deoxyribonucleic Acid) in Patients With mCRC (Metastatic Colorectal Cancer) During Treatment With Anti-EGFR (Epidermal Growth Factor Receptor) Therapy (EmutRAS)

Metastatic Colorectal Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Pain Monitoring After Breast Biopsy: Benefit of E-health (BIO-PSY)

Breast Cancer | Biopsy Wound

France
Institut du Cancer de Montpellier - Val d'Aurelle

Active, not recruiting

Safety, Tolerability and Efficacy of Regorafenib in Combination With FOLFIRINOX in Patients With Colorectal Cancer (FOLFIRINOX-R)

Metastatic Colorectal Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Active, not recruiting

A Phase II Trial Evaluating an Organ-conserving Strategy by Radiochemotherapy for Muscle-infiltrative Bladder Cancer (GETUGV04)

Infiltrating Bladder Urothelial Carcinoma

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Intraoperative Radiotherapy After Local Recurrence in Breast Cancer (RE-IORT01)

Breast Carcinoma

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Management of Perioperative Anxiety by the Cardiac Coherence Technique Coupled With a Hypnosis Session (COHEC)

Breast Cancer | Gynecologic Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Active, not recruiting

Breast-Conserving Surgery and Whole-Breast Radiation Therapy With or Without Additional Radiation Therapy to the Tumor in Treating Women With Ductal Carcinoma in Situ (BONBIS) (BONBIS)

Breast Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Active, not recruiting

Observational Study of Intra-operative Partial Irradiation of Invasive Ductal Breast Carcinomas With a Good Prognosis (INTRA-OBS)

Invasive Breast Cancer | Breast-conserving Surgery

France
Institut du Cancer de Montpellier - Val d'Aurelle

Terminated

Analysis of cfDNA in Patients With Hepatocarcinoma and Treated by Sorafenib or Regorafenib (HELP)

Hepatocarcinoma

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Precoce Medical Care by the Mobil Support for Patients With Glioblastoma (GLIOSUPPORT)

Glioblastoma

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Quality of Life and Neurocognitive Functioning (TEMOIN)

Glioma

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Evaluation of the Prevalence of Pelvic Static Disorders in Women With Localized Breast Cancer (STATICBREAST)

Breast Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Evaluation of Sexual Quality of Life for Breast Cancer (CUPIDON2)

Quality of Life | Cancer | Breast Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Prognostic and Predictive Value of HE4 Biomarker in Metastatic Ovarian Cancer (Meta-Four)

Metastatic Ovarian Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Medical and Surgical Management of Patients With Brain Metastases (CEREMET-LR)

Central Nervous System Tumor

France
Institut du Cancer de Montpellier - Val d'Aurelle

Terminated

2nd-line Treatment of Metastatic Colorectal Cancer (BEVATOMOX)

Metastatic Colorectal Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Effect of a Program of Physical Activity and Nutritional Therapeutic Education in Breast Cancer Patients (APAD2)

Breast Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Study of Vitamin D Supplementation Tailored to Vitamin D Deficiency in Breast Cancer Patients (VITACAL)

Breast Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Evaluation of Healthcare Workers Safety During Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC-Secure)

Healthy Volunteers | Safety

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Multicenter Phase 2 Trial: a Tailored Strategy for Locally Advanced Rectal Carcinoma (GRECCAR4)

Rectal Carcinoma | Locally Advanced Malignant Neoplasm

France
Institut du Cancer de Montpellier - Val d'Aurelle

Not yet recruiting

Assessment the sExual Quality of Life in Breast Cancer Patients Receiving oncoSexology Supportive Care on Proactive Versus On-request (VENUS)

Breast Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Not yet recruiting

Evaluation of the Impact of Multidisciplinary Oncosexology Management Associated With Photobiomodulation on Sexual Quality of Life in Women With Breast Cancer (EVABIOSEIN)

Breast Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Precision Imaging for Early Detection and Targeted Treatment Monitoring in Pancreatic Cancer (PANC-O-MICS)

Pancreas Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Unravelling Tumour Biology In Ovarian Cancer With Precision Imaging (MR-O-MICS)

High Grade Serous Ovarian Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Not yet recruiting

SAHARA-04 : Adaptive Radiotherapy in Hypersensitive Patients and High Locoregional Risk Breast Cancer With ETHOS Technology (SAHARA-04)

Breast Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

A Clinico-biological Database in Cachexia in Patients With Colon Cancer (BCB Cachexie)

Colon Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Assessment of Patients' Quality of Sexual Life After Anal Cancer Treatment (SEQUOIA)

Anxiety | Anal Cancer | HPV | Sexuality | Psychologic Stress

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Efficacy of Gembrax Followed by Folfirinox Versus Folfirinox Alone in First Metastatic Line Pancreatic Cancer Patients (GABRINOX2)

Metastatic Pancreatic Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Professional Life After Breast Cancer: Feasibility of a Coaching Program for an Adapted Return to Work (VISIBILITE)

Breast Cancer

France

3

Subscribe